Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating Inflammation
Molecular Pharmaceutics · 2025
DOI: 10.1021/acs.molpharmaceut.4c01328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2025. Verfasst von Guihong Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Health Science Center, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen …. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Oxidative Stress, Curcuma, Nanoparticles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
Inflammation and oxidative stress are important features of traumatic ulcerative colitis (UC). Turmeric has been used as a dietary and functional ingredient for its potent anti-inflammatory effects in UC therapy. However, its practical effectiveness is hindered by limited reactive oxygen species (ROS) elimination properties. To address this, we constructed a unique treatment agent by growing cerium oxide (CeO2) nanocrystals on the membranes of turmeric-derived nanovesicles (TNVs), named as TNV-Ce. The resulted TNV-Ce could suppress inflammation and exhibit exceptional ROS-scavenging activity, which was validated both in lipopolysaccharide-induced macrophages and dextran sulfate sodium salt-induced chronic colitis mouse model. Following oral administration, TNV-Ce significantly accumulated at inflamed sites, effectively eliminating ROS and inhibiting pro-inflammatory cytokines for synergistic action against UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Health Science Center, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
- Center for Child Care and Mental Health (CCCMH), Shenzhen Children's Hospital, Shenzhen 518038, China.
- Department of Pathology, Longgang Central Hospital of Shenzhen, Shenzhen, Guangdong 518116, China.
- State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Enginee…
- College of Pharmaceutical Science, Zhejiang University of Technology, Huzhou, Zhejiang 313201, China.
ORCID-Profile: Lin Mei
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Shenzhen Science and Technology Innovation Program
- Shenzhen Medical Research Fund
- Science and Technology Research Project of colleges and universities in Hebei Province
Zitieren
APA
Lu, G., Lu, S., Dai, H., Zhang, F., Wang, X., Li, W., Mei, L., & Tan, H. (2025). Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating Inflammation. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c01328
Vancouver
Lu G, Lu S, Dai H, Zhang F, Wang X, Li W, et al. Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating Inflammation. Molecular Pharmaceutics. 2025. doi:10.1021/acs.molpharmaceut.4c01328
BibTeX
@article{Lu2025,
author = {Lu, Guihong and Lu, Shanming and Dai, Haibing and Zhang, Fan and Wang, Xiaotian and Li, Weiqun and Mei, Lin and Tan, Hui},
title = {Engineered Turmeric-Derived Nanovesicles for Ulcerative Colitis Therapy by Attenuating Oxidative Stress and Alleviating Inflammation},
journal = {Molecular Pharmaceutics},
year = {2025},
doi = {10.1021/acs.molpharmaceut.4c01328}
}
EUVIMED